DNAJC5 and malaria: Anti-sporozoite vaccines, such as RTS,S, which target P. falciparum circumsporozoite protein (CSP) expressed on the surface of sporozoites, are leading malaria vaccine candidates undergoing phase III clinical trials in malaria-endemic areas [11, 12].